FDA approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.
Read more: FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs